Identifying Poor-Prognosis Colorectal Cancer Using MRI Alone — Development of a Preoperative Diagnostic AI Reducing Burden on Patients and Healthcare Costs
NQ Score
89/100
N1 Content Completeness
9
AI Summary (NQ-processed)
A research team led by Professor Wenchao Gu of Chiba University Graduate School of Medicine and Professor Tong Tong of Fudan University Cancer Hospital has developed an AI system that accurately identifies aggressive, hard-to-treat subtypes of colorectal cancer (CMS4) from preoperative MRI scans. Validated across three hospitals with 253 patients, the model achieved high accuracy and successfully stratified recurrence risk, paving the way for personalized treatment planning.
AI Analysis
Frequently Asked Questions
- Q: What does this AI technology enable?
- A: It enables non-invasive, high-accuracy prediction of high-risk CMS4 colorectal cancer using only preoperative MRI scans.
- Q: When will this technology be clinically applied?
- A: Clinical implementation is targeted within a few years through prospective multicenter studies.
- Q: What is CMS4 colorectal cancer?
- A: CMS4 is a molecular subtype resistant to chemotherapy and immunotherapy, with high recurrence risk and the worst prognosis.